Genenta’s TemferonTM: Evidence of Controlled and Targeted Interferon Expression in Preliminary Phase I/II Clinical Data in Glioblastoma Multiforme

Posted on November 16, 2020 by genenta
Press Releases

CONTACT

Via Olgettina 58
20132 Milano
Italy

    LaunchLabs - Alexandria Center
14th Floor
Suite 1456E
430 East 29th Street
New York NY 10016
United States

Email Inquiry

I read the information pursuant to art. 13 of EU Regulation no. 2016/679 concerning the protection of personal data
Please confirm that you have read the information on the processing of personal data
© 2015 genenta science. All Rights Reserved

Terms & Conditions - Cookie Policy